Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044794 · ClinicalTrials.gov registry record · NA
Daily Self-Weighing for Obesity Management in Primary Care
A NA study of Overweight and Obesity, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 396
- Enrollment target
- 1
- Study location
NCT04044794: Completed NA study of Overweight and Obesity, sponsored by University of Alabama at Birmingham.
NCT04044794 is a NA study of Overweight and Obesity that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 396 participants, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04044794, a NA study of Overweight and Obesity, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 396 participants
- Enrollment target
- 1
- Study location
Study Summary
Many adults with obesity continue to gain weight even though they do not want to. This project will test the effects of a primary care intervention in which people with obesity receive an electronic scale and recommendations to weigh themselves daily. This will help us understand whether daily self-weighing might be a way to prevent continued weight gain.
Primary Outcome
Body weight measured to the nearest 0.1 kg using a calibrated electronic scale
Conditions Studied
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Daily Self-Weighing
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2020-11-04 |
| Est. Completion | 2025-10-13 |
| Phase | NA |
What the finished NCT04044794 record still lists
NCT04044794 is an interventional study that assigns participants to a tested intervention. The registered 396 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (76% higher).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT04044794 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04044794 about?
NCT04044794 is a clinical study titled "Daily Self-Weighing for Obesity Management in Primary Care". Many adults with obesity continue to gain weight even though they do not want to. This project will test the effects of a primary care intervention in which people with obesity receive an electronic scale and recommendations to weigh themselves daily. This will help us understand whether daily self-...
What is the current status of trial NCT04044794?
This trial is currently completed. It is a NA study. The enrollment target is 396 participants. The study started on 2020-11-04. Estimated completion is 2025-10-13.
What conditions does trial NCT04044794 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT04044794?
The interventions under investigation include: Standard Care (BEHAVIORAL), Daily Self-Weighing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04044794?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04044794 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04044794's enrollment target sits among peer trials
396 19th of 115 higher than 97 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- NCT06545331 · 396 participants · Phase 1
Study of XB010 in Subjects With Solid Tumors
- NCT06666790 · 396 participants · NA
DermaSensor Postmarket Surveillance Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI